JAK2 Inhibitor V,Z3 chemical structure
Chemical structureResearch use only
CAT. NO. DC7436Featured

JAK2 Inhibitor V,Z3

Pack Sizes & Prices

TotalUS$500
We match the best price and quality on market.
Product overview

Description & Application

JAK2 Inhibitor V, Z3 is a cell-permeable pyridinylbutanone compound that inhibits both JAK2 and the active V167F mutant cellular autophosphorylation. JAK2 Inhibitor V, Z3 displays no effect against cellular Tyk 2 autophosphorylation in COS cells or SRC in cell-free kinase assays. JAK2 Inhibitor V, Z3 suppresses the JAK2-V167F-dependent proliferation of the erythroleukemia cell line HEL by blocking the G1-S transition and is shown to effectively reduce the cytokine-stimulated growth of both Jak2-V617F-positive and Jak2-F537I-positive primary hematopoietic progenitor cells from myeloproliferative disorder patients.For the detailed information of JAK2 Inhibitor V, the solubility of JAK2 Inhibitor V in water, the solubility of JAK2 Inhibitor V in DMSO, the solubility of JAK2 Inhibitor V in PBS buffer, the animal experiment (test) of JAK2 Inhibitor V, the cell expriment (test) of JAK2 Inhibitor V, the in vivo, in vitro and clinical trial test of JAK2 Inhibitor V, the EC50, IC50,and Affinity of JAK2 Inhibitor V, Please contact DC Chemicals.

ParameterValue
Chemical NameZ3; NSC 42834; 1-Butanone, 2-methyl-1-phenyl-4-(2-pyridinyl)-2-[2-(2-pyridinyl)ethyl]-
CAS No.195371-52-9
SynonymsZ3; NSC 42834; 1-Butanone, 2-methyl-1-phenyl-4-(2-pyridinyl)-2-[2-(2-pyridinyl)ethyl]-
FormulaC23H24N2O
M.Wt344.5
SMILESC(C1=CC=CC=C1)(=O)C(C)(CCC1=NC=CC=C1)CCC1=NC=CC=C1
Purity>98%
Storage2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological Activity

JAK2 Inhibitor V, Z3 is a cell-permeable pyridinylbutanone compound that inhibits both JAK2 and the active V167F mutant cellular autophosphorylation. JAK2 Inhibitor V, Z3 displays no effect against cellular Tyk 2 autophosphorylation in COS cells or SRC in cell-free kinase assays. JAK2 Inhibitor V, Z3 suppresses the JAK2-V167F-dependent proliferation of the erythroleukemia cell line HEL by blocking the G1-S transition and is shown to effectively reduce the cytokine-stimulated growth of both Jak2-V617F-positive and Jak2-F537I-positive primary hematopoietic progenitor cells from myeloproliferative disorder patients.For the detailed information of JAK2 Inhibitor V, the solubility of JAK2 Inhibitor V in water, the solubility of JAK2 Inhibitor V in DMSO, the solubility of JAK2 Inhibitor V in PBS buffer, the animal experiment (test) of JAK2 Inhibitor V, the cell expriment (test) of JAK2 Inhibitor V, the in vivo, in vitro and clinical trial test of JAK2 Inhibitor V, the EC50, IC50,and Affinity of JAK2 Inhibitor V, Please contact DC Chemicals.

In Vitro

No in vitro data are provided in the current product source. Contact us for further information.

In Vivo

No in vivo data are provided in the current product source. Contact us for further information.

References & source

DC Chemicals original product information

Published experimental findings depend on the model and assay conditions. They do not guarantee equivalent performance in every application. For laboratory research use only.

Product documentation

Refer to the certificate supplied with your lot for batch-specific release results.

Handling guide

2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Solution calculator

Related research products

AZD1480 chemical structureDC5032

AZD1480

AZD1480 is a novel ATP-competitive JAK2 inhibitor with IC50 of 0.26 nM, selectivity against JAK3 and Tyk2, and to a smaller extent against JAK1. IC50 value: 0.26 nM Target: JAK2 in vitro: AZD1480 demonstrated…

View activity & prices
BMS-911543 chemical structureDC4175

BMS-911543

BMS-911543 is a selective JAK2 inhibitor, with IC50s of 1.1 nM, less selective at JAK1, JAK3 and TYK2 (IC50, 75, 360, 66 nM, respectively).

View activity & prices
TG101209 chemical structureDC7317

TG101209

TG101209 is a selective JAK2 inhibitor with IC50 of 6 nM, less potent to Flt3 and RET with IC50 of 25 nM and 17 nM, appr 30-fold selective for JAK2 than JAK3, and sensitive to JAK2V617F and MPLW515L/K mutations.

View activity & prices

Cart

Request quotation